Cargando…
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
The combination of nicotinamide and carbogen breathing is awaiting clinical evaluation as a strategy to overcome tumour hypoxia and thus enhance radiation response. We have continued our evaluation of this approach in the murine SCCVII tumour with the aim of determining the importance of nicotinamid...
Autores principales: | Chaplin, D. J., Horsman, M. R., Siemann, D. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968547/ https://www.ncbi.nlm.nih.gov/pubmed/8347481 |
Ejemplares similares
-
Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
por: Chaplin, D. J., et al.
Publicado: (1991) -
Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.
por: Rojas, A., et al.
Publicado: (1993) -
Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.
por: Laurence, V. M., et al.
Publicado: (1995) -
Perfluorocarbon nanodroplets can reoxygenate hypoxic tumors in vivo without carbogen breathing
por: Xiang, Yun, et al.
Publicado: (2019) -
Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.
por: Hoskin, P. J., et al.
Publicado: (1997)